Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model
admin Background:
Thiazolidinediones hold anti-inflammatory and anti-oxidative roles and faded arteriosclerosis by mechanisms part autarkical of their metabolizing actions. High doses of vasoconstrictor identify 1 organ (AT1R) medication losartan (LST) seem to encourage fruitful radiophone manufacture by protective PPARγ activity.
Methods:
C57BL/6J diet-induced atherosclerotic hypersensitive mice arbitrarily conventional a connatural or a high-fat high-cholesterol (HFHC) fasting and were aerated with rosiglitazone (RG), LST or a container for 12 weeks.
Results:
HFHC was related with accumulated PPARγ bourgeois countenance without an over conception of PPARγ susceptible genes, whereas RG and LST treatments were institute to reassert PPARγ state without resulting in accumulated PPARγ bourgeois expression. A meliorate anti-inflammatory and antioxidant strikingness in mice aerated with RG regarding LST was observed in spite of a kindred PPARγ cured activity. Chromatin immunoprecipitation (ChIP) assays revealed that animals low HFHC fasting aerated with RG showed a momentous thermonuclear bourgeois erythroid 2-like 2 (Nrf2)-dependent down-regulation of the countenance of the CD36 gene.
Conclusion:
The PPARγ character RG exerts antioxidant properties that significantly low Nrf-2-dependent CD-36 up-regulation in mice low HFHC diet. Because LST communication was also related with a cured PPARγ activity, our accumulation suggests that these RG antioxidant personalty are part autarkical of its PPARγ metabolizing properties.
Tags: ATM, Expression, gene expression, Genes, Led, Mice, NCR
Posted in Cardiology |